NCT03981380View on ClinicalTrials.gov

11C-PIB PET Study in MESA at Columbia University

CompletedOBSERVATIONAL
Enrollment

59

Participants

Timeline

Start Date

August 1, 2020

Primary Completion Date

February 5, 2024

Study Completion Date

February 5, 2024

Conditions
Cognitive ImpairmentVascular DiseasesAlzheimer DiseaseAtherosclerosis
Interventions
DRUG

11C-PIB

Participants will be injected with an intravenous bolus of up to 5-15mCi (370 MBq) (+/-10%) of \[11C\]PiB (over 5-10 seconds).

Trial Locations (1)

10032

Columbia University Irving Medical Center, New York

All Listed Sponsors
collaborator

Wake Forest University

OTHER

collaborator

National Institute on Aging (NIA)

NIH

lead

José A. Luchsinger

OTHER

NCT03981380 - 11C-PIB PET Study in MESA at Columbia University | Biotech Hunter | Biotech Hunter